These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8698625)

  • 1. Antiproliferative effect of a novel cholecystokinin-B/gastrin receptor antagonist, YM022.
    Murayama T; Matsumori Y; Iwata N; Ito M; Taniguchi T; Chihara K; Matsui T
    Jpn J Cancer Res; 1996 Jul; 87(7):743-50. PubMed ID: 8698625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo- 5-phenyl-1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo.
    Nishida A; Miyata K; Tsutsumi R; Yuki H; Akuzawa S; Kobayashi A; Kamato T; Ito H; Yamano M; Katuyama Y
    J Pharmacol Exp Ther; 1994 May; 269(2):725-31. PubMed ID: 7910212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-B receptors.
    Singh P; Owlia A; Espeijo R; Dai B
    J Biol Chem; 1995 Apr; 270(15):8429-38. PubMed ID: 7721737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effect of YM022, an antiulcer agent in rats, on human cholecystokinin (CCK)B/gastrin receptor.
    Koizumi T; Saita Y; Miyake A; Nishida A; Yazawa H; Honda K
    Jpn J Pharmacol; 1996 Aug; 71(4):307-13. PubMed ID: 8886928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor].
    Artru P; Attoub S; Levasseur S; Lewin MJ; Bado A
    Gastroenterol Clin Biol; 1998; 22(6-7):607-12. PubMed ID: 9762332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
    Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
    Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells.
    Iwata N; Murayama T; Matsumori Y; Ito M; Nagata A; Taniguchi T; Chihara K; Matsuo Y; Minowada J; Matsui T
    Blood; 1996 Oct; 88(7):2683-9. PubMed ID: 8839863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
    Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
    Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
    Zhou W; Povoski SP; Bell RH
    J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
    Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1,4- benzodiazepin-3-yl]-3-(3-methylphenyl)urea]: an irreversible cholecystokinin type-B receptor antagonist.
    Dunlop J; Brammer N; Evans N; Ennis C
    Biochem Pharmacol; 1997 Jul; 54(1):81-5. PubMed ID: 9296353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
    Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
    Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of a human brain cholecystokinin-B receptor. A trophic effect of cholecystokinin and gastrin.
    Ito M; Matsui T; Taniguchi T; Tsukamoto T; Murayama T; Arima N; Nakata H; Chiba T; Chihara K
    J Biol Chem; 1993 Aug; 268(24):18300-5. PubMed ID: 8349705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G; Ryder H; Rooker DP; Batt AR; Kendrick DA; Szelke M; Ohta M; Satoh M; Nishida A; Akuzawa S; Miyata K
    J Med Chem; 1997 Jan; 40(3):331-41. PubMed ID: 9022799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intrathecally administered FK480, a cholecystokinin-A receptor antagonist, and YM022, a cholecystokinin-B receptor antagonist, on the formalin test in the rat.
    Yamamoto T; Nozaki-Taguchi N
    Anesth Analg; 1996 Jul; 83(1):107-13. PubMed ID: 8659718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cloned human cholecystokinin-B receptor as a gastrin receptor.
    Miyake A; Mochizuki S; Kawashima H
    Biochem Pharmacol; 1994 Apr; 47(8):1339-43. PubMed ID: 8185642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists.
    Satoh M; Kondoh Y; Okamoto Y; Nishida A; Miyata K; Ohta M; Mase T; Murase K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2159-67. PubMed ID: 8582018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
    Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines.
    Monstein HJ; Ohlsson B; Axelson J
    Scand J Gastroenterol; 2001 Jul; 36(7):738-43. PubMed ID: 11444473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.